You are here

References

Export 23 results:

Author Title Type [ Year

]

Submitted

Submitted.

2017

M. C. van Maaren, Bretveld, R. W., Jobsen, J. J., Veenstra, R. K., Groothuis-Oudshoorn, C. Gm, Struikmans, H., Maduro, J. H., Strobbe, L. Ja, Poortmans, P. Mp, and Siesling, S., “The influence of timing of radiation therapy following breast-conserving surgery on 10-year disease-free survival.”, Br J Cancer, vol. 117, no. 2, pp. 179-188, 2017.

2016

M. C. van Maaren, de Munck, L., de Bock, G. H., Jobsen, J. J., van Dalen, T., Linn, S. C., Poortmans, P., Strobbe, L. J. A., and Siesling, S., “10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.”, Lancet Oncol, vol. 17, no. 8, pp. 1158-1170, 2016.

M. C. van Maaren, Poortmans, P., and Siesling, S., “Breast-conserving therapy versus mastectomy.”, Oncoscience, vol. 3, no. 11-12, pp. 304-305, 2016.

M. C. van Maaren, de Munck, L., Jobsen, J. J., Poortmans, P., de Bock, G. H., Siesling, S., and Strobbe, L. J. A., “Breast-conserving therapy versus mastectomy in T1-2N2 stage breast cancer: a population-based study on 10-year overall, relative, and distant metastasis-free survival in 3071 patients.”, Breast Cancer Res Treat, vol. 160, no. 3, pp. 511-521, 2016.

A. Wauters and Van Hoyweghen, I., “Global trends on fears and concerns of genetic discrimination: a systematic literature review.”, J Hum Genet, vol. 61, no. 4, pp. 275-82, 2016.

E. C. Wijnvoord, Buitenhuis, J., Brouwer, S., van der Klink, J. J. L., and de Boer, M. R., “Health-based risk neutralization in private disability insurance.”, Eur J Public Health, vol. 26, no. 6, pp. 1045-1049, 2016.

L. E. C. Wijnvoord, Brouwer, S., Buitenhuis, J., van der Klink, J. J. L., and de Boer, M. R., “Indications of a Scarring Effect of Sickness Absence Periods in a Cohort of Higher Educated Self-Employed.”, PLoS One, vol. 11, no. 5, p. e0156025, 2016.

2015

G. Singh, Salkind, A. R., and Kneepkens, R. F., “Suitability of HIV-Infected Subjects for Insurance.”, J Insur Med, vol. 45, no. 1, pp. 34-41, 2015.

R. F. Kneepkens, “Time Dependent Relative Risks in Life Insurance Medical Underwriting.”, J Insur Med, vol. 45, no. 2, pp. 88-97, 2015.

2014

R. F. Kneepkens and Lindeboom, R., “Age dependent decline of relative risks in life insurance medical underwriting.”, J Insur Med, vol. 44, no. 3, pp. 170-83, 2014.

Y. Joly, Burton, H., Knoppers, B. Maria, Feze, I. Ngueng, Dent, T., Pashayan, N., Chowdhury, S., Foulkes, W., Hall, A., Hamet, P., Kirwan, N., Macdonald, A., Simard, J., and Van Hoyweghen, I., “Life insurance: genomic stratification and risk classification.”, Eur J Hum Genet, vol. 22, no. 5, pp. 575-9, 2014.

L. E. C. Wijnvoord, van der Klink, J. J. L., de Boer, M. R., and Brouwer, S., “Predictors of sickness absence in college and university educated self-employed: a historic register study.”, BMC Public Health, vol. 14, p. 420, 2014.

2013

A. Rita Pereira, Vieira, D. Nuno, and Magalhães, T., “Fatal intimate partner violence against women in Portugal: a forensic medical national study.”, J Forensic Leg Med, vol. 20, no. 8, pp. 1099-107, 2013.

J. Kaulich-Bartz, Dam, W., May, M. T., Lederberger, B., Widmer, U., Phillips, A. N., Grabar, S., Mocroft, A., Vilaro, J., van Sighem, A., Moreno, S., Dabis, F., Monforte, A. D. 'Arminio, Teira, R., Ingle, S. M., and Sterne, J. A. C., “Insurability of HIV-positive people treated with antiretroviral therapy in Europe: collaborative analysis of HIV cohort studies.”, AIDS, vol. 27, no. 10, pp. 1641-55, 2013.

2012

R. F. Kneepkens, “Fracastoro and the prognosis of applicants with HIV.”, J Insur Med, vol. 43, no. 2, pp. 61-3, 2012.

E. Geelen, Horstman, K., Marcelis, C. L. M., Doevendans, P. A., and Van Hoyweghen, I., “Unravelling fears of genetic discrimination: an exploratory study of Dutch HCM families in an era of genetic non-discrimination acts.”, Eur J Hum Genet, vol. 20, no. 10, pp. 1018-23, 2012.

2011

E. Aarden, Van Hoyweghen, I., and Horstman, K., “Constructing access in predictive medicine. Comparing classification for hereditary breast cancer risks in England, Germany and the Netherlands.”, Soc Sci Med, vol. 72, no. 4, pp. 553-9, 2011.

P. Proença, Franco, J. Miguel, Mustra, C., Marcos, M., Pereira, A. Rita, Corte-Real, F., and Vieira, D. Nuno, “An UPLC-MS/MS method for the determination of valproic acid in blood of a fatal intoxication case.”, J Forensic Leg Med, vol. 18, no. 7, pp. 320-4, 2011.

2008

I. Van Hoyweghen and Horstman, K., “European practices of genetic information and insurance: lessons for the Genetic Information Nondiscrimination Act.”, JAMA, vol. 300, no. 3, pp. 326-7, 2008.

2007

I. Van Hoyweghen, Horstman, K., and Schepers, R., “Genetic 'risk carriers' and lifestyle 'risk takers'. Which risks deserve our legal protection in insurance?”, Health Care Anal, vol. 15, no. 3, pp. 179-93, 2007.

2006

I. Van Hoyweghen, Horstman, K., and Schepers, R., “Making the normal deviant: the introduction of predictive medicine in life insurance.”, Soc Sci Med, vol. 63, no. 5, pp. 1225-35, 2006.

2005

I. Van Hoyweghen, Horstman, K., and Schepers, R., “'Genetics is not the issue': insurers on genetics and life insurance.”, New Genet Soc, vol. 24, no. 1, pp. 79-98, 2005.